Active ingredient
Alogliptin
10 finished FDA listings contain Alogliptin as their only active ingredient; 13 combination products also contain it.
FDA NDC Directory
- Ingredient names as written by FDA
- ALOGLIPTIN BENZOATE
- Dosage forms
- Tablet, Film Coated
- Routes
- Oral
- Manufacturers / labelers
- 5
- Strengths listed
- 12.5 mg/1 · 25 mg/1 · 6.25 mg/1
- Brand names in FDA listings
- Nesina
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 1368001
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 022271 | TAKEDA PHARMS USA | 2013-01-25 | 10 |
Official labeling on DailyMed
- ALOGLIPTIN TABLET, FILM COATED [PADAGIS ISRAEL PHARMACEUTICALS LTD] · version 12 · 2025-05-01
- NESINA (ALOGLIPTIN) TABLET, FILM COATED [TAKEDA PHARMACEUTICALS AMERICA, INC.] · version 22 · 2025-03-24
- ALOGLIPTIN TABLET, FILM COATED [BRYANT RANCH PREPACK] · version 1 · 2025-01-30
- ALOGLIPTIN TABLET, FILM COATED [A-S MEDICATION SOLUTIONS] · version 6 · 2023-10-25
- ALOGLIPTIN TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] · version 4 · 2023-02-03
- ALOGLIPTIN TABLET, FILM COATED [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] · version 2 · 2022-10-19
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.